Research: TAYEBI-KHOSROSHAHI and COLLEAGUES,

Listed in Issue 236

Abstract

TAYEBI-KHOSROSHAHI and COLLEAGUES, (1)Chronic Kidney Disease Research Center, Imam Reza Hospital and Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. farid.panahi@gmail.com evaluated the effect of omega-3 supplementation on serum homocysteine level in patients on  haemodialysis.

Background

Patients with end-stage renal disease are at a high risk of adverse cardiovascular events. Elevated level of homocysteine is an important risk factor for cardiovascular morbidity and mortality in dialysis patients. There are some strategies for reduction of serum homocysteine level in these patients, including folate and vitamin supplementation. The aim of the present study was to evaluate the effect of omega-3 supplementation on serum homocysteine level in patients on haemodialysis.

Methodology

In a randomized controlled trial, 100 haemodialysis patients were assigned into two groups to receive omega-3 (oral capsule, 3 g/d) or placebo for 2 months. Complete blood count, blood urea nitrogen, serum creatinine, serum lipids, and serum homocysteine levels were measured before the study and after 2 months at the end of study.

Results

Of 100 patients, 6 in each group were excluded, and 44 patients in each group completed the study. There were no significant differences regarding the age, sex, and the number of dialysis sessions per week between the two groups. No difference was observed between the two groups in the laboratory investigations at the end of the study, except for a significant reduction in serum homocysteine level in the omega-3 group as compared to the placebo group (P = .03).

Conclusion

Our study showed a significant reduction regulated by omega-3 supplementation in serum homocysteine level which is a cardiovascular risk factor among haemodialysis patients. Omega-3 can be considered as another homocysteine-reducing agent in this population.

References

Tayebi-Khosroshahi H(1), Dehgan R, Habibi Asl B, Safaian A, Panahi F, Estakhri R, Purasgar B. Effect of omega-3 supplementation on serum level of homocysteine in hemodialysis  patients. Iran J Kidney Dis. 7(6):479-84. Nov 2013. Comment in Iran J Kidney Dis. 7(6):421-2. Nov 2013.

Comment

The above research out of Iran documents the significant reduction in haemodialysis patients of serum homocysteine levels, regulated by omega-3 supplementation, a cardiovascular risk factor among these patients.

Munro Hall Clinic 2018

IJCA 2018 New Skyscraper

Scientific and Medical Network 2

Walk on the Wide Side Trek Kenya 2020

top of the page